MelaFind Evaluations for Patients With Multiple Nevi
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01700101|
Recruitment Status : Completed
First Posted : October 4, 2012
Last Update Posted : August 26, 2014
We have added objectives 4-6 to our updated study:
Study Objective 1: To determine whether the distribution of MelaFind scores is different for different patients with multiple nevi, and whether such distributions can be utilized to identify "signature" lesions for a given patient.
Study Objective 2: To investigate whether distributions of quantitative ABCD parameters differ among patients and whether these qABCD parameters identify "signature" lesions.
Study Objective 3: To determine the feasibility of defining and using relative thresholds to improve the specificity of MelaFind without sacrificing its high sensitivity.
Study Objective 4: To determine the repeatability of MelaFind scores for a given lesion for different patient and lesion characteristics.
Study Objective 5: To identify patient and lesion characteristics that result in the highest variability of MelaFind scores for a given lesion.
Study Objective 6: To use standard errors of MelaFind scores to propose a robust individual threshold for lesions to be considered for biopsy to rule out melanoma on patients with multiple nevi.
|Condition or disease|
|Clinically Atypical Pigmented Skin Lesion|
|Study Type :||Observational|
|Actual Enrollment :||19 participants|
|Official Title:||MelaFind Evaluations for Patients With Multiple Nevi|
|Study Start Date :||November 2012|
|Actual Primary Completion Date :||June 2014|
|Actual Study Completion Date :||June 2014|
- Multiple values and standard deviations of MelaFind scores for pigmented skin lesions [ Time Frame: 1 month ]